Status:
COMPLETED
A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.
Lead Sponsor:
Pfizer
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the effectiveness of PD-217,014 in the treatment of abdominal pain/discomfort associated with irritable bowel disease.
Eligibility Criteria
Inclusion
- Males and females having Irritable bowel syndrome as defined by the Rome II criteria.
- Patients must have had normal examination of colon anatomy within the last 5 years
Exclusion
- Patient with an organic gastrointestinal disease.
- Patients with poor renal function.
- Patients with severe constipation.
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
End Date :
February 1 2005
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT00139672
Start Date
January 1 2004
End Date
February 1 2005
Last Update
June 17 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.